Jared Teo

Jared joined HealthQuest in 2018 and brings a unique breadth and depth of experiences. His prior roles include: an operator at medical device companies, an investment banker at Goldman Sachs, and most recently, an investor at the Health Innovation Fund. Jared currently serves as board observer for HealthQuest portfolio companies Ajax Health and CleanSlate and as a board member at Etairos.

The foundation of Jared’s experience is in medical device R&D. At FoxHollow Technologies (acquired by eV3), Kerberos Proximal Solutions (acquired by FoxHollow) and CryoCor (acquired by Boston Scientific), Jared led the conception, development and commercialization of innovative devices in several therapeutic areas, first as an R&D Engineer and later as an R&D Project Manager.

At Goldman Sachs, Jared advised clients across the life sciences, diagnostics and medical device industries on M&A transactions and public equity/debt financings. He was responsible for complex financial analyses and day-to-day transaction execution.

Most recently, at the Health Innovation Fund Jared executed several investments in health IT and tech-enabled services companies, and closely collaborated with management teams post investment.

Jared received a B.S. in Bioengineering from UC San Diego and an MBA from The Wharton School at the University of Pennsylvania. Jared is an aspiring photographer and fitness enthusiast.